Editorial: Studying novel immune signatures, targets, and drugs in hepatobiliary tumors: based on advanced technologies

Overview of attention for article published in Frontiers in immunology, November 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 33,822 followers.

RT @FrontImmunol: New Research: Editorial: Studying novel immune signatures, targets, and drugs in hepatobiliary tumors: based on advanced…

13 Nov 2023

Reply Repost Favourite

RT @FrontImmunol: New Research: Editorial: Studying novel immune signatures, targets, and drugs in hepatobiliary tumors: based on advanced…

13 Nov 2023

Reply Repost Favourite

New Research: Editorial: Studying novel immune signatures, targets, and drugs in hepatobiliary tumors: based on advanced technologies https://t.co/rYQ3uzkyed #immunology

13 Nov 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.